Cytokinetics Inc. buy Truist Financial Co.
Start price
08.04.24
/
50%
€68.00
Target price
08.04.25
€79.21
Performance (%)
-18.38%
Price
08:31
€55.50
Summary
This prediction is currently active. The price of Cytokinetics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -18.38%. This prediction currently runs until 08.04.25. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Cytokinetics Inc. | 2.804% | 2.804% |
iShares Core DAX® | 0.051% | 5.593% |
iShares Nasdaq 100 | 1.808% | 7.445% |
iShares Nikkei 225® | 2.181% | 2.815% |
iShares S&P 500 | 1.040% | 4.975% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $86.00 price target on the stock.
Ratings data for CYTK provided by MarketBeat